FI954243A7 - Farmaseuttiset yhdisteet - Google Patents
Farmaseuttiset yhdisteet Download PDFInfo
- Publication number
- FI954243A7 FI954243A7 FI954243A FI954243A FI954243A7 FI 954243 A7 FI954243 A7 FI 954243A7 FI 954243 A FI954243 A FI 954243A FI 954243 A FI954243 A FI 954243A FI 954243 A7 FI954243 A7 FI 954243A7
- Authority
- FI
- Finland
- Prior art keywords
- pharmaceutical compounds
- pharmaceutical
- compounds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Psychiatry (AREA)
- Heart & Thoracic Surgery (AREA)
- Pain & Pain Management (AREA)
- Cardiology (AREA)
- Hospice & Palliative Care (AREA)
- Obesity (AREA)
- Urology & Nephrology (AREA)
- Diabetes (AREA)
- Child & Adolescent Psychology (AREA)
- Addiction (AREA)
- Anesthesiology (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Otolaryngology (AREA)
- Hematology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Steroid Compounds (AREA)
- Optical Integrated Circuits (AREA)
- Holo Graphy (AREA)
- Gyroscopes (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB9418326A GB9418326D0 (en) | 1994-09-12 | 1994-09-12 | Pharmaceutical compounds |
| GBGB9511166.2A GB9511166D0 (en) | 1995-06-02 | 1995-06-02 | Pharmaceutical compounds |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| FI954243A0 FI954243A0 (fi) | 1995-09-11 |
| FI954243A7 true FI954243A7 (fi) | 1996-03-13 |
Family
ID=26305611
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI954243A FI954243A7 (fi) | 1994-09-12 | 1995-09-11 | Farmaseuttiset yhdisteet |
Country Status (22)
| Country | Link |
|---|---|
| EP (1) | EP0705832B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JPH0881464A (cg-RX-API-DMAC7.html) |
| KR (1) | KR960010635A (cg-RX-API-DMAC7.html) |
| CN (1) | CN1045602C (cg-RX-API-DMAC7.html) |
| AT (1) | ATE247114T1 (cg-RX-API-DMAC7.html) |
| AU (1) | AU698580B2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2157998A1 (cg-RX-API-DMAC7.html) |
| CZ (1) | CZ286565B6 (cg-RX-API-DMAC7.html) |
| DE (1) | DE69531476T2 (cg-RX-API-DMAC7.html) |
| ES (1) | ES2204932T3 (cg-RX-API-DMAC7.html) |
| FI (1) | FI954243A7 (cg-RX-API-DMAC7.html) |
| HU (1) | HU219491B (cg-RX-API-DMAC7.html) |
| IL (1) | IL115236A (cg-RX-API-DMAC7.html) |
| IN (1) | IN179550B (cg-RX-API-DMAC7.html) |
| MY (1) | MY132009A (cg-RX-API-DMAC7.html) |
| NO (1) | NO305174B1 (cg-RX-API-DMAC7.html) |
| NZ (1) | NZ272961A (cg-RX-API-DMAC7.html) |
| PE (1) | PE41796A1 (cg-RX-API-DMAC7.html) |
| PH (1) | PH31631A (cg-RX-API-DMAC7.html) |
| PL (1) | PL310373A1 (cg-RX-API-DMAC7.html) |
| RU (1) | RU2146256C1 (cg-RX-API-DMAC7.html) |
| TR (1) | TR199501114A2 (cg-RX-API-DMAC7.html) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2308362A (en) * | 1995-12-19 | 1997-06-25 | Lilly Industries Ltd | Pharmaceutical indole derivatives |
| EP0905136A1 (en) * | 1997-09-08 | 1999-03-31 | Janssen Pharmaceutica N.V. | Tetrahydro gamma-carbolines |
| UA70334C2 (en) * | 1998-10-06 | 2004-10-15 | Janssen Pharmaceutica N V Jans | BENZOTHIENO[3,2-c]PYRIDINES AS a2 ANTAGONISTS BENZOTHIENO[3,2-c]PYRIDINES AS a2 ANTAGONISTS |
| UA74826C2 (en) * | 2000-05-17 | 2006-02-15 | Ortho Mcneil Pharm Inc | ?-carboline derivatives as phosphodiesterase inhibitors |
| AU2001278875B2 (en) * | 2000-07-06 | 2007-06-07 | The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Tetrahydrobenzothiazole analogues as neuroprotective agents |
| DE10040016A1 (de) * | 2000-08-16 | 2002-02-28 | Boehringer Ingelheim Pharma | Neue beta-Amyloid Inhibitoren, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel |
| CA2417081C (en) * | 2000-09-19 | 2008-08-05 | Enzo Cereda | New n, n'-disubstituted benzimidazolone derivatives with affinity at the serotonin and dopamine receptors |
| CA2417082C (en) * | 2000-09-19 | 2009-11-17 | Enzo Cereda | New benzimidazolone derivatives displaying affinity at the serotonin and dopamine receptors |
| US6586435B2 (en) | 2000-09-19 | 2003-07-01 | Boehringer Ingelheim Pharma Kg | Benzimidazolone derivatives displaying affinity at the serotonin and dopamine receptors |
| US7183410B2 (en) | 2001-08-02 | 2007-02-27 | Bidachem S.P.A. | Stable polymorph of flibanserin |
| US6849640B2 (en) | 2001-08-08 | 2005-02-01 | Pharmacia & Upjohn Company | Therapeutic 1H-pyrido [4,3-b] indoles |
| UA78974C2 (en) | 2001-10-20 | 2007-05-10 | Boehringer Ingelheim Pharma | Use of flibanserin for treating disorders of sexual desire |
| US10675280B2 (en) | 2001-10-20 | 2020-06-09 | Sprout Pharmaceuticals, Inc. | Treating sexual desire disorders with flibanserin |
| RU2232578C1 (ru) * | 2003-04-10 | 2004-07-20 | Ахапкина Валентина Ивановна | Вещество, обладающее антидепрессивной активностью |
| PL1912650T3 (pl) | 2005-08-03 | 2018-01-31 | Sprout Pharmaceuticals Inc | Zastosowanie flibanseryny w leczeniu otyłości |
| EP1945214A1 (en) | 2005-10-29 | 2008-07-23 | Boehringer Ingelheim International GmbH | Benzimidazolone derivatives for the treatment of premenstrual and other female sexual disorders |
| US20090312242A1 (en) | 2006-06-30 | 2009-12-17 | Ramiro Castro | Flibanserin for the treatment of urinary incontinence and related diseases |
| CL2007002214A1 (es) | 2006-08-14 | 2008-03-07 | Boehringer Ingelheim Int | Composicion farmaceutica en la forma de comprimido, donde al menos la longitud del comprimido en el estado anterior de la aplicacion es al menos 7/12 del diametro pilorico del paciente y despues de ingerirlo en estado alimentado, la longitud del comp |
| WO2008019996A2 (en) | 2006-08-14 | 2008-02-21 | Boehringer Ingelheim International Gmbh | Formulations of flibanserin and method for manufacturing the same |
| MX2009002031A (es) | 2006-08-25 | 2009-03-06 | Boehringer Ingelheim Int | Sistema de liberacion controlada y metodo para fabricarlo. |
| UY31335A1 (es) | 2007-09-12 | 2009-04-30 | Tratamiento de sintomas vasomotores | |
| MX2011012537A (es) | 2009-05-29 | 2011-12-14 | Sumitomo Chemical Co | Agente para el tratamiento o prevencion de enfermedades asociadas con actividad de factores neurotroficos. |
| NZ779654A (en) * | 2015-10-01 | 2024-12-20 | Olema Pharmaceuticals Inc | Tetrahydro-1h-pyrido[3,4-b]indole anti-estrogenic drugs |
| JP7616794B2 (ja) | 2019-07-07 | 2025-01-17 | オレマ ファーマシューティカルズ インク． | エストロゲン受容体アンタゴニストのレジメン |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4035369A (en) | 1975-10-08 | 1977-07-12 | Janssen Pharmaceutica N.V. | 1-Benzazolylalkyl-4-substituted-piperidines |
| IL69132A (en) * | 1982-07-14 | 1986-02-28 | Roussel Uclaf | Benzo-and naphtho-thiopyranopyrimidinones,their preparation and pharmaceutical compositions containing them |
| US4636563A (en) * | 1985-09-16 | 1987-01-13 | American Home Products Corporation | Antipsychotic γ-carbolines |
| FR2661177A1 (fr) * | 1990-04-23 | 1991-10-25 | Rhone Poulenc Sante | Derives du naphtosultame antagonistes de la serotonine, leur preparation et les medicaments les contenant. |
-
1995
- 1995-09-07 ES ES95306253T patent/ES2204932T3/es not_active Expired - Lifetime
- 1995-09-07 DE DE69531476T patent/DE69531476T2/de not_active Expired - Fee Related
- 1995-09-07 EP EP95306253A patent/EP0705832B1/en not_active Expired - Lifetime
- 1995-09-07 AT AT95306253T patent/ATE247114T1/de not_active IP Right Cessation
- 1995-09-08 PH PH51266A patent/PH31631A/en unknown
- 1995-09-08 AU AU30497/95A patent/AU698580B2/en not_active Ceased
- 1995-09-08 CZ CZ19952322A patent/CZ286565B6/cs not_active IP Right Cessation
- 1995-09-08 MY MYPI95002675A patent/MY132009A/en unknown
- 1995-09-08 HU HU9502631A patent/HU219491B/hu not_active IP Right Cessation
- 1995-09-08 NZ NZ272961A patent/NZ272961A/en unknown
- 1995-09-11 IN IN1079CA1995 patent/IN179550B/en unknown
- 1995-09-11 FI FI954243A patent/FI954243A7/fi unknown
- 1995-09-11 RU RU95115522A patent/RU2146256C1/ru active
- 1995-09-11 PL PL95310373A patent/PL310373A1/xx unknown
- 1995-09-11 IL IL115236A patent/IL115236A/en not_active IP Right Cessation
- 1995-09-11 KR KR1019950029475A patent/KR960010635A/ko not_active Ceased
- 1995-09-11 CN CN95117133A patent/CN1045602C/zh not_active Expired - Fee Related
- 1995-09-11 CA CA002157998A patent/CA2157998A1/en not_active Abandoned
- 1995-09-11 NO NO953575A patent/NO305174B1/no not_active IP Right Cessation
- 1995-09-11 JP JP7231873A patent/JPH0881464A/ja active Pending
- 1995-09-12 PE PE1995278830A patent/PE41796A1/es not_active Application Discontinuation
- 1995-09-12 TR TR95/01114A patent/TR199501114A2/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| FI954243A0 (fi) | 1995-09-11 |
| HU9502631D0 (en) | 1995-11-28 |
| TR199501114A2 (tr) | 1996-10-21 |
| CN1045602C (zh) | 1999-10-13 |
| DE69531476D1 (de) | 2003-09-18 |
| EP0705832B1 (en) | 2003-08-13 |
| NZ272961A (en) | 1998-02-26 |
| IN179550B (cg-RX-API-DMAC7.html) | 1997-10-18 |
| JPH0881464A (ja) | 1996-03-26 |
| RU2146256C1 (ru) | 2000-03-10 |
| HU219491B (hu) | 2001-04-28 |
| ES2204932T3 (es) | 2004-05-01 |
| KR960010635A (ko) | 1996-04-20 |
| MY132009A (en) | 2007-09-28 |
| PE41796A1 (es) | 1996-10-21 |
| NO305174B1 (no) | 1999-04-12 |
| PL310373A1 (en) | 1996-03-18 |
| CZ286565B6 (cs) | 2000-05-17 |
| HUT72593A (en) | 1996-05-28 |
| DE69531476T2 (de) | 2004-06-09 |
| AU698580B2 (en) | 1998-11-05 |
| CN1129219A (zh) | 1996-08-21 |
| CA2157998A1 (en) | 1996-03-13 |
| IL115236A (en) | 1998-06-15 |
| NO953575L (no) | 1996-03-13 |
| IL115236A0 (en) | 1995-12-31 |
| CZ232295A3 (en) | 1996-03-13 |
| AU3049795A (en) | 1996-03-28 |
| EP0705832A1 (en) | 1996-04-10 |
| PH31631A (en) | 1999-01-12 |
| ATE247114T1 (de) | 2003-08-15 |
| NO953575D0 (no) | 1995-09-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI970995L (fi) | Farmaseuttisia yhdisteitä | |
| FI971018L (fi) | Farmaseuttisia yhdisteitä | |
| FI971279A0 (fi) | Lääkkeitä | |
| DK0777671T3 (da) | Spiro-azabicykliske forbindelser | |
| FI971260A7 (fi) | 1-asyyli-4-alifatyyliaminopiperidiiniyhdisteet | |
| FI973243L (fi) | Uusi farmaseuttinen yhdistelmä | |
| DK0769017T3 (da) | Terapeutiske forbindelser | |
| FI954243A7 (fi) | Farmaseuttiset yhdisteet | |
| NO972937D0 (no) | Farmasöytiske piperazinforbindelser | |
| BR9610214A (pt) | Compostos farmacéuticos | |
| BR9508339A (pt) | Medicamento | |
| NO934145L (no) | Farmasöytiske forbindelser | |
| BR9507768A (pt) | Composição farmacêutica | |
| FI931251A7 (fi) | Farmaseuttisia yhdisteitä | |
| FI970151A0 (fi) | Viruksenvastaisesti vaikuttavia difluoristatoniyhdisteitä | |
| ITMI942166A0 (it) | Composizioni farmaceutiche miorilassanti | |
| FI951155A7 (fi) | Farmaseuttinen valmiste | |
| FI964918L (fi) | Lääkeainesuoloja | |
| NO965448D0 (no) | Farmasöytiske forbindelser | |
| BR9509740A (pt) | Compostos 18-nor-vitamina d | |
| FI950737A7 (fi) | Lääkkeitä | |
| FI971971A7 (fi) | Pyridatsinokinoliiniyhdisteitä | |
| FI962738L (fi) | Farmaseuttiset koostumukset | |
| FI954050A7 (fi) | Lääkekoostumuksia | |
| NO962816D0 (no) | Farmasöytiske forbindelser |